title: [Prescription of high-cost medicines in French Hospitals: Regulation and procedures of reimbursement].
abstract: The high cost of several drugs or medical devices involves specific reimbursement procedures in French hospitals. Specific prescription rules have been developed and a regular survey by regional health authorities is performed. These particular funding procedures allow patients to access to innovative drugs. Some questions have recently been raised in France about the list of cancer drugs that could be concerned by an additional funding by health insurance. In this setting, this article proposes to summarize the current modalities of reimbursement of high-cost medicines in French Hospitals to enlighten the current debate.
authors.affiliation: Faculté de pharmacie, 16, boulevard Daviers, 49000 Angers, France.
authors.forename: Cécile
authors.initials: C
authors.lastname: Wilkowsky
authors.affiliation: Hôpital Louis-Pasteur, service de pharmacie, 28630 Chartres-le-Coudray, France.
authors.forename: Adélaïde
authors.initials: A
authors.lastname: Lenain
authors.affiliation: Hôpital Louis-Pasteur, service de pharmacie, 28630 Chartres-le-Coudray, France.
authors.forename: Khaled
authors.initials: K
authors.lastname: Benbekhaled
authors.affiliation: Hôpital Louis-Pasteur, service de pharmacie, 28630 Chartres-le-Coudray, France.
authors.forename: Marie-José
authors.initials: MJ
authors.lastname: Le Gall
authors.affiliation: Hôpital Louis-Pasteur, service d'oncologie-hématologie, 6, rue Claude-Bernard, 28630 Chartres-le-Coudray, France. Electronic address: svignot@ch-chartres.fr.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vignot
mesh_terms: D000970:Antineoplastic Agents / Q000145:classification / Q000191:economics*; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics* / Q000592:standards; D005602:France; D006761:Hospitals; D017410:Practice Guidelines as Topic; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence*
chemical_list: D000970:Antineoplastic Agents
keywords: Cancer; Contrat de bon usage; Groupe homogène de séjour; Health insurance; Reimbursement of high-cost medicines; Remboursement des molécules onéreuses